Introducing dengue vaccine: Implications for diagnosis in dengue vaccinated subjects
- PMID: 27142330
- DOI: 10.1016/j.vaccine.2016.04.070
Introducing dengue vaccine: Implications for diagnosis in dengue vaccinated subjects
Abstract
Diagnosis of dengue virus infections is complicated by preference for different diagnostic tests in different post onset days of illness and the presence of multiple serotypes leading to secondary and tertiary infections. The sensitivity of the most commonly employed diagnostic assays such as anti dengue IgM capture (MAC) ELISA and non structural protein (NS) 1 capture ELISA are lower in secondary and subsequent infections. Introduction of dengue vaccine in endemic regions will affect the way how dengue is diagnosed in vaccinated subjects. This viewpoint article discusses implications of introduction of dengue vaccine on the diagnosis of dengue infections in vaccinated subjects and the strategies that are needed to tackle the issue.
Keywords: Dengue; Dengvaxia; Diagnosis; IgM; NS1 antigen ELISA.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction.Vaccine. 2016 May 23;34(24):2707-12. doi: 10.1016/j.vaccine.2016.04.028. Epub 2016 Apr 18. Vaccine. 2016. PMID: 27102820 Clinical Trial.
-
Detection of dengue infection by combining the use of an NS1 antigen based assay with antibody detection.Southeast Asian J Trop Med Public Health. 2011 Mar;42(2):297-302. Southeast Asian J Trop Med Public Health. 2011. PMID: 21710849
-
Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans.J Clin Microbiol. 2015 Feb;53(2):557-66. doi: 10.1128/JCM.02735-14. Epub 2014 Dec 10. J Clin Microbiol. 2015. PMID: 25502522 Free PMC article.
-
A review of dengue diagnostics and implications for surveillance and control.Trans R Soc Trop Med Hyg. 2019 Nov 1;113(11):653-660. doi: 10.1093/trstmh/trz068. Trans R Soc Trop Med Hyg. 2019. PMID: 31365115 Free PMC article. Review.
-
Updates on Dengue Vaccine and Antiviral: Where Are We Heading?Molecules. 2021 Nov 9;26(22):6768. doi: 10.3390/molecules26226768. Molecules. 2021. PMID: 34833860 Free PMC article. Review.
Cited by
-
Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection.Front Immunol. 2016 Dec 7;7:531. doi: 10.3389/fimmu.2016.00531. eCollection 2016. Front Immunol. 2016. PMID: 28003809 Free PMC article. Review.
-
Computational Advancement towards the Identification of Natural Inhibitors for Dengue Virus: A Brief Review.Comb Chem High Throughput Screen. 2024;27(17):2464-2484. doi: 10.2174/0113862073244468230921050703. Comb Chem High Throughput Screen. 2024. PMID: 37859315 Review.
-
Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach.Drug Des Devel Ther. 2016 Oct 11;10:3163-3181. doi: 10.2147/DDDT.S117369. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27784988 Free PMC article.
-
Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.Emerg Microbes Infect. 2017 Nov 8;6(11):e99. doi: 10.1038/emi.2017.87. Emerg Microbes Infect. 2017. PMID: 29116222 Free PMC article.
-
Aedes aegypti resistance development to commonly used insecticides in Jakarta, Indonesia.PLoS One. 2017 Dec 18;12(12):e0189680. doi: 10.1371/journal.pone.0189680. eCollection 2017. PLoS One. 2017. PMID: 29253003 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous